Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Kaja Abbas et autres
0 citationsThe Lancet Infectious Diseases
Laura Bough
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
22Publications signalées
4455Citations signalées
0Affiliations récentes
Domaines associés
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19interferon and immune responsesDiabetes Treatment and Management
Publications récentes
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jonathan R. Abbas et autres
11 citationsThe Lancet Infectious Diseases
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Gianmarco Leone, Francesco Orlando, Peter Dutey‐Magni, Osvaldas Vainauskas et autres
5 citationsJAMA Oncology
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jaffar Abbas et autres
3 citationsEClinicalMedicine
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
Jannik Boos, Caspar I. van der Made, Gayatri Ramakrishnan, Eamon Coughlan et autres
12 citationsHuman Genetics and Genomics Advances
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Saul N. Faust, Richard Haynes, Christine E. Jones, Natalie Staplin et autres
40 citationsThe Lancet Child & Adolescent Health
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
PK Judge, Natalie Staplin, KJ Mayne, Christoph Wanner et autres
121 citationsThe Lancet Diabetes & Endocrinology
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
Natalie Staplin, Richard Haynes, PK Judge, Christoph Wanner et autres
98 citationsThe Lancet Diabetes & Endocrinology
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jonathan R. Abbas et autres
41 citationsThe Lancet Diabetes & Endocrinology
A second update on mapping the human genetic architecture of COVID-19
Shea J. Andrews, Mattia Cordioli, Christine Stevens, Mark J. Daly et autres
124 citationsNature
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Erola Pairo‐Castineira, Konrad Rawlik, Andrew D. Bretherick, Ting Qi et autres
10 citationsNature
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Erola Pairo‐Castineira, Konrad Rawlik, Andrew D. Bretherick, Ting Qi et autres
231 citationsNature
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.